pentobarbital will lessen the extent or outcome of buprenorphine, lengthy-performing injection by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Individuals who transfer to buprenorphine prolonged-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers should be monitored to